ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SCLP Scancell Holdings Plc

9.60
0.00 (0.00%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Holdings Plc LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.60 9.40 9.80 9.60 9.60 9.60 114,837 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 5.27M -11.94M -0.0129 -7.44 89.07M
Scancell Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 9.60p. Over the last year, Scancell shares have traded in a share price range of 7.65p to 18.125p.

Scancell currently has 927,819,977 shares in issue. The market capitalisation of Scancell is £89.07 million. Scancell has a price to earnings ratio (PE ratio) of -7.44.

Scancell Share Discussion Threads

Showing 11776 to 11795 of 65925 messages
Chat Pages: Latest  477  476  475  474  473  472  471  470  469  468  467  466  Older
DateSubjectAuthorDiscuss
18/9/2017
14:31
Inanaco, you said:
"Tosh ... why can i achieve in a sentence that you take half a page over"

I agree, you achieved a great detail in that single sentence (or is it 2?) and highlighted a major risk. You say the value is in the IP protected by patent. The patent for Moditope has not been granted - that is a risk.

So you very successfully argue against yourself - nothing new there!

gazza
18/9/2017
14:29
what that means in practice

Because your reliant on another's opinion, it means you cannot evaluate risk, so you spread the risk across a sector

inanaco
18/9/2017
14:08
Just for the record.
Risks are very much associated with your investment, not your personal circumstances.
As with everything, some investments carry more risk than others, hence agency ratings of bonds - shares - banks - and indeed, where bonds are concerned, the relevant yields being offered that reflect the RISK of default / repayment. Most regulated financial instruments carry a clear risk ratio, anyone who says differently clearly doesn't understand the most basic rules. The risks of the investment are calculated by a rating agency, NOT by you personally ... These by definition, are " investment risks ", not personal risk... Personal risks are something completely different.

Does Vodafone carry the same risk as Scancell... No of course it doesn't... There is a clear differential in investment risk.
Having looked at the investment risk, only then can you determine your personal appetite based off the investment risk.

tosh123
18/9/2017
13:39
Not at all, as risk can only ever be applied to your personal circumstance as its how you see it, so it can only be your own opinion ..nothing more ...
inanaco
18/9/2017
13:32
And you're ignoring the risks!
gazza
18/9/2017
13:24
Its a baby Bio ... That's not disputed, Trials fail, not disputed, however each Bio has a very defined IP covered by Patent .. as such its very much an individual, You cannot just apply a blanket risk factor in that instance, as its far more precise. Like saying wind electric generators carry the same risk as nuclear power stations...
just because they both produce electricity. So you have to refine down to sector Ie..DNA vaccines, which maybe, can assist ie Inovio etc. but how do you refine the sector of Moditope ??? you just cannot, it has no peer ... which means your back to applying sector risk again. Which Has no meaning in context ... because your ignoring the IP.

inanaco
18/9/2017
13:20
ONW,
I make you right sir. As for a " baby bio " i think that Scancell sits very well in that category with a market cap of circa £40 mill, and zero revenues, plus further trials and fund raising on the horizon.
All vaccines are still currently unproven, hence the requirement for further trials, and the fact that there has still been no " buying " interest from any of the majors.

Failure could still come, and the industry knows this, as does the market in general, hence the current share price. The marketability of any of the platforms is NOT a done deal, nor is it anything other than RISKY.
One hopes and prays that the existing data is further proven and clarified sufficiently to allow eventual progress to mainstream treatment, but that is still some way off, and the pitfalls are deep and many.

tosh123
18/9/2017
13:02
Are you saying SCLP is not a baby bio and therefore exempt from any actions/policy one would adopt in the sector?
gazza
18/9/2017
12:20
ONW

Your posting on a Scancell BB, not a baby bio BB, so you can actually tighten up your post rather than post a vague policy across the sector. Because your adding failure into the mix as if SCIB1 failed.. Thus your post might be sensible to an investor with no experience, but reads poorly to a experienced investor in Scancell. Your investment in Scancell is Buy and hold, regardless of top slice blah blah, you have maintained a holding on the expectation of a deal at some point. Your level of holding only dictates your own personal risk assessment of the sector not of Scancell.

inanaco
18/9/2017
10:27
C7 11770
you say,
"....but would really appreciate no more posts alluding to my honesty and integrity, two things i value and haven"t lost. ATB"
C7 Was that sentence addressed to me?

oldnotwise
18/9/2017
10:20
11767 ONW............exactly, we can omit the "adrenalin junkie" lol. Just thought opening up after the Final Report 7% down, we would retrace a bit more. Don"t think anyone sold more than my 13.15 but the sells seem to have dried up. Still feel comfortable holding a bit of cash, but also happy to buy back in less. If we go up i am happy too. There will certainly be many opportunities to trade this. As i said many a time in my quest for 100k i never really had enough to trade, a 30% trading pot seems balanced, time will tell, but a strategy all folks i am in touch with tend to use.
The only reason i declared it was i had never sold before, just felt the need to fess up. Possibly wrong, my posts wont change, as accused by inanaco, but would really appreciate no more posts alluding to my honesty and integrity, two things i value and haven"t lost. ATB

chelsea35
18/9/2017
09:48
drdobson 11768
Hate so say it mate, but your 11768 is doing exactly what you advise others not to do!
Please take this in the manner it's intended, it's not in any way aimed against you, merely an observation.
ATB

oldnotwise
18/9/2017
09:40
Morning Lozan
Yes never tempted by feeding the tRHYPE hound as the ASTUTE can read NANA like a penny book.
When HE is rumbled by ALL IN and FUNDING is NO ISSUE he tries to claim moral high ground OR baffles everyone with inane ramblings about science.

His arrogance,lack of personal and communication skills,and crypto babble on the science should raise a BIG RED FLAG.IGNORE.

Most people just AVOID his ADVICE and save money by npbeing ASTUTE

drdobson
18/9/2017
09:30
C7
In fairness I think it would be wise to sit down and work out what sort of strategy you want to apply to your funds in the future.
In essence are you an investor/Trader/Gambler/Adrenaline Junkie or whatever.
Once you know that then you're in a position to think what to do next.
There's no right and wrong answers to this, and things can change, but the main consideration is what you want to achieve with your available "pot".
There's only one person who can answer that , and that's you!
ATB

oldnotwise
18/9/2017
09:08
""straightforward""!!! Hmmm, all i do know is I would have been much better off buying 250k at 6p. Buying in at 41p has dictated my stratagy really, from day one. Selling at 28p would have left me with losses at that point. Thanks anyway, but we have had numerous conversations on the same thing. "Buying on the dips" another one that is questionable, our chart looks a bit like a ski slope!!!
chelsea35
18/9/2017
09:06
ONW Nicely balanced post.Wish I had enough money to spread the risk but you give wise words.
drdobson
18/9/2017
08:23
C7 Apols
The answer I would give to your question is quite straightforward.
The notoriety of AIM Baby Bios should IMO set off warning bells when an investor decides to BUY.
Why?
Because the failure rate for such companies is high, the journey to commercialisation can be erratic to say the least.
An investor in revenue positive companies is looking for the dividends (Income) payable to shareholders to begin to flow and increase over time as the company's profits grow.
This is why any investor in even a company like Scancell is in it for .... ie they're looking for PROFITS to be derived from the successful development of the IP.
As the business that Scancell is in is high risk most INVESTORS (rather than speculative traders) would expect to have as many failures in their portfolios as winners (and that's an optimistic way of putting it), and so anyone who is an investor (rather than an out and out gambler) would want to have a spread of such stocks forming part of a larger portfolio, and even the sector involvement in Biotechnology would only form a (relatively) small proportion of the overall portfolio's value. The idea being simply that many baby bios will fail so hopefully with good research and a bit of luck some will blossom and produce that dividend income that gives the shares real value.
So for an INVESTOR a "Buy and Hold" policy makes sense, but that buy and hold requires time and other investments to spread the risk.
This is the reason that I've always been wary of the "all in" and other "Gambler" mentality approaches that have been propagated in SCLP as The share is high risk and by definition not suitable for anyone who has a limited investment pot who wishes to INVEST rather than GAMBLE.
If "Buy and Hold" doesn't suit the means/investment strategy of an INDIVIDUAL I'd like to suggest saying that it's stupid isn't necessarily correct, it certainly isn't stupid for my approach.
Hope this clarifies my position.
AIMO
ATB

oldnotwise
18/9/2017
07:50
ONW, you never actually replied to my 11743.
chelsea35
18/9/2017
07:40
oldnotwise, you engaged me yesterday, felt i wanted to end that rift as i have tried to do before. I sincerely hope that was your intention to, lets see.
chelsea35
17/9/2017
19:57
Wig .. understands you better now Loz
inanaco
Chat Pages: Latest  477  476  475  474  473  472  471  470  469  468  467  466  Older

Your Recent History

Delayed Upgrade Clock